Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2010
11/11/2010WO2010128787A2 Gadolinium complex, method for preparing same, and mri contrast agent comprising same
11/11/2010WO2010107178A3 Magnetic resonance imaging contrast agent with paramagnetic-inositol phosphates complexes
11/11/2010WO2009092516A3 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
11/11/2010US20100287627 Transgenic Zebrafish Models for Neurodegenerative Diseases
11/11/2010US20100287626 Method of screening ptp zeta activity promoter or inhibitor
11/11/2010US20100286510 Use of fluorescent phospholipid ether compounds in biopsies
11/11/2010US20100286375 Carrier molecules
11/11/2010US20100285605 Neurofibrillary labels
11/11/2010US20100285049 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
11/11/2010US20100284936 Contrast agents
11/11/2010US20100284935 Markers and diagnostic methods for metastasis
11/11/2010US20100284934 Diagnostic agent
11/11/2010US20100284933 Biomarkers of Multiple Sclerosis
11/11/2010US20100284931 Fluorescent phospholipid ether compounds, compositions, and methods of use
11/11/2010US20100284929 Fluorescent imaging of tumors using phospholipid ether compounds
11/11/2010US20100284928 Methods for in vivo atherosclerotic plaque characterization using magnetic susceptibility to identify symptom-producing plaques
11/11/2010US20100284927 Use of mri contrast agents for evaluating the treatment of tumors
11/11/2010US20100284926 Use of g-csf for the treatment of stroke
11/11/2010US20100284925 Small Molecule Intervention for Obesity
11/11/2010US20100284924 Nano-devices having impellers for capture and release of molecules
11/11/2010US20100284923 Methods of diagnosing latent and active malignancies
11/11/2010US20100284922 Marker
11/11/2010US20100284921 Targeted nanoparticles for intracellular cancer therapy
11/11/2010US20100284920 Uses of monoclonal antibody 8h9
11/11/2010US20100284919 Injectable Radio-Opaque Compositions for Tissue Augmentation
11/11/2010US20100284918 Protein
11/11/2010US20100284917 Compounds and markers for surface-enhanced raman scattering
11/11/2010US20100284916 Antibodies Against Human Cytomegalovirus (HCMV)
11/11/2010US20100284915 Genes associated with chemotherapy response and uses thereof
11/11/2010US20100284913 Methods and compositions for studying, imaging, and treating pain
11/11/2010US20100284910 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers
11/11/2010US20100284907 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells
11/10/2010EP2249273A1 Systems and methods for managing information relating to medical fluids and containers therefor
11/10/2010EP2248900A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
11/10/2010EP2247315A2 Mixed ligand core/shell iron oxide nanoparticles for inflammation imaging
11/10/2010EP2247314A1 Cationic contrast agents and methods of use thereof
11/10/2010EP2247313A2 Ester imaging agents
11/10/2010EP1997076B1 Cascade analysis for intestinal contraction detection
11/10/2010EP1631318B1 Magnetic nanoparticles linked to a ligand
11/10/2010EP1590007B1 Improved radiometal complex compositions
11/10/2010CN1990048B Ultrasonic therapy couplant, its preparing process and packing apparatus
11/10/2010CN1901940B Polymeric marker with high radiopacity for use in medical devices
11/10/2010CN101883785A New non-selective somatostatin analogues
11/10/2010CN101881760A Method for measuring toxic hazard effect of toxic chemical
11/10/2010CN101314049B Novel targeted microbubble contrast medium
11/10/2010CN101306841B Particles with superparamagnetism and method for manufacturing same
11/09/2010US7829526 DNA encoding peptide, an antibody against the peptide; cardioinhibitory, hypotensive agent; peptide as an active ingredient; marker protein, peptide tag
11/09/2010US7829103 immunogenic composition consisting of, as an active principle, a pure methylated heparin-binding hemagglutinin (HBHA) protein in a pharmaceutically acceptable formulation, and one or more adjuvants
11/09/2010US7829066 Assay for anti-metastatic agents
11/09/2010CA2590388C A staining composition for staining an ophthalmic membrane
11/09/2010CA2441609C Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
11/09/2010CA2161684C Bioactive and/or targeted dendrimer conjugates
11/04/2010WO2010127136A2 Measurement of body fluid volumes
11/04/2010WO2010126319A2 Lipopeptide with specific affinity to the fc region of an antibody, and antigen-recognizing lipid nanoparticle comprising same
11/04/2010WO2010126075A1 Fluorescent probe for detecting npp
11/04/2010WO2010125907A1 Composition for diagnosis of conformational disease
11/04/2010WO2010125088A2 Nanoparticle contrast agents for diagnostic imaging
11/04/2010WO2010125068A2 Labeled molecular imaging agents, methods of making and methods of use
11/04/2010WO2010101628A3 Methods and products for in vivo enzyme profiling
11/04/2010WO2010085797A3 Arginase inhibitors and methods of use
11/04/2010US20100281547 Selecting animals for desired genotypic or potential phenotypic properties
11/04/2010US20100280493 Methods and Systems for Treating Injured Cardiac Tissue
11/04/2010US20100280232 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/04/2010US20100280177 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/04/2010US20100278997 Preparation for restenosis prevention
11/04/2010US20100278753 Device and Method for the Diagnosis of Gastrointestinal Allergy
11/04/2010US20100278751 Radiolabeled 2-amino-4-alkyl-6-(haloalkyl)pyridine compounds and their use in diagnostic imaging
11/04/2010US20100278750 Polylysine dendrimer contrast agent
11/04/2010US20100278749 Nanoparticle contrast agents for diagnostic imaging
11/04/2010US20100278748 Nanoparticle contrast agents for diagnostic imaging
11/04/2010US20100278747 Carrier
11/04/2010US20100278746 Method for Measuring Neurotransmitters in Vivo
11/04/2010US20100278744 Preparation for restenosis prevention
11/04/2010US20100278743 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling
11/04/2010US20100278742 Methods and compositions for detection and diagnosis of infectious diseases
11/04/2010US20100278741 Novel compositions including sphingosine kinase type 1 inhibitors, and processes for using same
11/04/2010US20100278740 Streptococcus pneumoniae proteins and nucleic acid molecules
11/04/2010US20100278739 Targeted, nir imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging
11/04/2010US20100278738 Method to detect and monitor ischemia in transplanted organs and tissues
11/04/2010US20100278737 Organic-inorganic hybrid particles containing contrast agent
11/04/2010US20100278736 FLT4 (VEGFR-3) as a Target for Tumor Imaging and Anti-Tumor Therapy
11/04/2010US20100278735 Methods for detection of vulnerable plaque with quantitative colorimetry during angeoscopy
11/04/2010US20100278734 Nanoparticle contrast agents for diagnostic imaging
11/04/2010US20100278733 Composition for diagnosis of amyloid-related disease
11/04/2010US20100278731 Mechanism-Based Targeted Pancreatic Beta Cell Imaging and Therapy
11/04/2010US20100278725 Methods and devices for lymphatic targeting
11/04/2010CA2759000A1 Labeled molecular imaging agents, methods of making and methods of use
11/03/2010EP2245004A2 Contrast agents
11/03/2010EP2245003A2 Contrast agents
11/03/2010EP2244742A2 Therapy selection method
11/03/2010EP2244741A2 Fluorescent imaging agents
11/03/2010EP0719273B1 Nucleotide analogs
11/03/2010CN101878213A Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
11/03/2010CN101878044A Non-spherical contrast agents for cest mri based on bulk magnetic susceptibility effect
11/03/2010CN101875961A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto
11/03/2010CN101875508A Preparation method of Fe3O4 nano-magnetic powder lymphatic tracer and application thereof
11/03/2010CN101874478A Mouse model for depression, schizophrenia and alzheimer's disease
11/03/2010CN101422622B B-ultrasonic traditional Chinese medicine imaging assistant and preparation method thereof
11/03/2010CN101400370B Method to assess surfactant adsorption on skin
11/02/2010US7824923 Screening for drugs which alter the amount, localization and/or characteristics of differentiation factors; use in enhancing the memory performance
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 354